Position in BMY
as of Mar 31, 2026
· filed May 8, 2026
Position Value
$1,023,628,015
+$86,904,250 QoQ
Shares Held
16,877,626
-2.8% QoQ
Ownership
0.826%
of shares outstanding
% of Portfolio
0.24%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 92.07416374791099.ToString("F0")%
Shared 0.ToString("F0")%
None 7.925836252089008.ToString("F0")%
Common Shares in BMY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026Legal & General Group Plc holds $25,087,571,930 across 12 Drug Manufacturers - General names. BMY ranks #9 (4.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AZN |
Astrazeneca PLC
|
25,849,978 | $5,098,132,659 | |
| 2 | LLY |
ELI LILLY & Co
|
5,379,364 | $4,947,777,626 | |
| 3 | JNJ |
Johnson & Johnson
|
19,347,862 | $4,729,391,386 | |
| 4 | ABBV |
AbbVie Inc.
|
12,159,427 | $2,644,553,777 | |
| 5 | MRK |
Merck & Co., Inc.
|
19,538,545 | $2,350,291,577 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
10,464,889 | $1,458,491,578 | |
| 7 | AMGN |
Amgen Inc
|
3,870,863 | $1,361,963,146 | |
| 8 | PFE |
Pfizer Inc
|
43,505,563 | $1,221,636,207 |
All Filings in BMY
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,023,628,015 | 16,877,626 | Shares | Defined | 2026-05-08 | |
| 2025-12-31 | $936,723,765 | 17,366,032 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $770,116,008 | 17,075,743 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $729,463,000 | 15,758,544 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $1,004,284,087 | 16,466,373 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $912,075,586 | 16,125,806 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $862,602,967 | 16,671,878 | Shares | Defined | 2025-02-28 | |
| 2024-06-30 | $686,640,614 | 16,533,605 | Shares | Defined | 2025-05-29 | |
| 2024-03-31 | $891,799,929 | 16,444,771 | Shares | Defined | 2025-05-29 | |
| 2023-12-31 | $856,519,111 | 16,693,025 | Shares | Defined | 2025-05-29 | |
| 2023-09-30 | $986,463,104 | 16,996,263 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $1,114,948,233 | 17,434,687 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $1,149,000,525 | 16,577,702 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $1,187,761,392 | 16,508,150 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $1,173,096,752 | 16,501,572 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,313,093,166 | 17,053,158 | Shares | Defined | 2022-08-22 | |
| 2022-03-31 | $1,196,102,648 | 16,378,237 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $947,071,122 | 15,189,593 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $936,170,994 | 15,821,717 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $1,007,660,833 | 15,080,228 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $907,991,150 | 14,382,879 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $897,462,382 | 14,468,199 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $862,887,480 | 14,312,282 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $867,863,185 | 14,759,578 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $861,120,067 | 15,448,871 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||